Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrer

Showing results (191-200 of 293) with videos related to

Pageof 30
Sort By:
Journal of Medicinal Chemistry|June 29, 2021
Discovery and Optimization of a 4-Aminopiperidine Scaffold for Inhibition of Hepatitis C Virus AssemblyAdam Rolt, Daniel C Talley, Seung Bum Park, et al.
SLAS Technology|October 6, 2018
Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug EfficacyKelli M Wilson, Lesley A Mathews-Griner, Tara Williamson, et al.
Journal of Medicinal Chemistry|April 29, 2020
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D<sub>3</sub> Dopamine Receptor AgonistAmy E Moritz, R Benjamin Free, Warren S Weiner, et al.
Nature Medicine|September 14, 2014
The intracellular Ca²⁺ channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophyXiping Cheng, Xiaoli Zhang, Qiong Gao, et al.
Revista Espanola De Cardiologia (English Ed.)|October 13, 2022
Mechanical complications in STEMI: prevalence and mortality trends in the primary PCI era. The Ruti-STEMI registryNabil El Ouaddi, Oriol de Diego, Carlos Labata, et al.
Journal of Medicinal Chemistry|June 22, 2017
Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication CycleShanshan He, Kelin Li, Billy Lin, et al.
Nature Communications|February 6, 2015
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacyHilary A Kenny, Madhu Lal-Nag, Erin A White, et al.
Scientific Reports|March 18, 2021
A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activityHouda G Khaled, Hongxuan Feng, Xin Hu, et al.
Nucleic Acids Research|July 17, 2008
Hit selection with false discovery rate control in genome-scale RNAi screensXiaohua Douglas Zhang, Pei Fen Kuan, Marc Ferrer, et al.
Nature Communications|February 4, 2016
Erratum: Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacyHilary A Kenny, Madhu Lal-Nag, Erin A White, et al.
Pageof 30

Showing results (191-200 of 293) with videos related to

Sort By:
Pageof 30
Journal of Medicinal Chemistry|June 29, 2021
Discovery and Optimization of a 4-Aminopiperidine Scaffold for Inhibition of Hepatitis C Virus AssemblyAdam Rolt, Daniel C Talley, Seung Bum Park, et al.
SLAS Technology|October 6, 2018
Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug EfficacyKelli M Wilson, Lesley A Mathews-Griner, Tara Williamson, et al.
Journal of Medicinal Chemistry|April 29, 2020
Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D<sub>3</sub> Dopamine Receptor AgonistAmy E Moritz, R Benjamin Free, Warren S Weiner, et al.
Nature Medicine|September 14, 2014
The intracellular Ca²⁺ channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophyXiping Cheng, Xiaoli Zhang, Qiong Gao, et al.
Revista Espanola De Cardiologia (English Ed.)|October 13, 2022
Mechanical complications in STEMI: prevalence and mortality trends in the primary PCI era. The Ruti-STEMI registryNabil El Ouaddi, Oriol de Diego, Carlos Labata, et al.
Journal of Medicinal Chemistry|June 22, 2017
Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication CycleShanshan He, Kelin Li, Billy Lin, et al.
Nature Communications|February 6, 2015
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacyHilary A Kenny, Madhu Lal-Nag, Erin A White, et al.
Scientific Reports|March 18, 2021
A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activityHouda G Khaled, Hongxuan Feng, Xin Hu, et al.
Nucleic Acids Research|July 17, 2008
Hit selection with false discovery rate control in genome-scale RNAi screensXiaohua Douglas Zhang, Pei Fen Kuan, Marc Ferrer, et al.
Nature Communications|February 4, 2016
Erratum: Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacyHilary A Kenny, Madhu Lal-Nag, Erin A White, et al.
Pageof 30